Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income	$ 51,563	$ 50,001
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on early extinguishment of debt	0	648
Depreciation and amortization of deferred leasing costs	36,227	36,899
Amortization of deferred debt costs	1,687	1,428
Compensation costs of stock and option grants	1,134	1,220
Credit losses (recoveries) on operating lease receivables, net	160	(20)
Increase in accounts receivable and accrued income	(731)	(3)
Additions to deferred leasing costs	(3,856)	(1,417)
Increase in other assets	(4,304)	(1,531)
Increase in accounts payable, accrued expenses and other liabilities	3,352	4,085
Increase (decrease) in deferred income	(192)	699
Net cash provided by operating activities	85,040	92,009
Cash flows from investing activities:
Additions to real estate investments	(18,612)	(12,215)
Additions to development and redevelopment projects	(128,655)	(72,294)
Net cash used in investing activities	(147,267)	(84,509)
Cash flows from financing activities:
Proceeds from notes payable	15,300	199,750
Repayments on notes payable	(33,910)	(166,290)
Proceeds from revolving credit facility	113,000	119,000
Repayments on revolving credit facility	(26,000)	(97,000)
Proceeds from construction loan	53,306	0
Payments of debt extinguishment costs	0	(593)
Additions to deferred debt costs	(423)	(9,800)
Proceeds from the issuance of:
Common stock	1,642	7,629
Partnership units	0	1,322
Distributions to:
Common stockholders	(42,527)	(41,364)
Noncontrolling interests	(16,458)	(16,062)
Net cash provided by (used in) financing activities	55,534	(11,803)
Net decrease in cash and cash equivalents	(6,693)	(4,303)
Cash and cash equivalents, beginning of period	13,279	14,594
Cash and cash equivalents, end of period	6,586	10,291
Supplemental disclosure of cash flow information:
Cash paid for interest	34,424	30,295
Accrued capital expenditures included in accounts payable, accrued expenses, and other liabilities	33,495	13,955
Series D Cumulative Redeemable, 30,000 shares issued and outstanding
Distributions to:
Preferred stockholders	(3,446)	(3,445)
Series E Cumulative Redeemable, 44,000 shares issued and outstanding
Distributions to:
Preferred stockholders	$ (4,950)	$ (4,950)